Tai Wan Kim
Overview
Explore the profile of Tai Wan Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bak M, Park H, Yoon H, Chung G, Shin H, Shin S, et al.
Front Mol Neurosci
. 2024 Mar;
17:1356453.
PMID: 38450042
Introduction: Pain that arises spontaneously is considered more clinically relevant than pain evoked by external stimuli. However, measuring spontaneous pain in animal models in preclinical studies is challenging due to...
2.
Lee J, Choi J, Kim J, Kim T, Kim J, Chung G, et al.
Molecules
. 2022 Dec;
27(23).
PMID: 36500231
Oxaliplatin-induced peripheral neuropathy (OIPN) is a serious side effect that impairs the quality of life of patients treated with the chemotherapeutic agent, oxaliplatin. The underlying pathophysiology of OIPN remains unclear,...
3.
Lee P, Kim T, Kim S
J Inequal Appl
. 2017 Feb;
2017(1):34.
PMID: 28216989
Elliptic obstacle problems are formulated to find either superharmonic solutions or minimal surfaces that lie on or over the obstacles, by incorporating inequality constraints. In order to solve such problems...
4.
Shin Y, Lee J, Jin L, Kim M, Oh J, Kim T, et al.
Biomater Res
. 2015 Sep;
18:14.
PMID: 26331065
Background: M13 bacteriophages can be readily fabricated as nanofibers due to non-toxic bacterial virus with a nanofiber-like shape. In the present study, we prepared hybrid nanofiber matrices composed of poly(lactic-co-glycolic...
5.
Shin Y, Yang W, Lee J, Oh J, Kim T, Park J, et al.
Int J Nanomedicine
. 2014 Sep;
9:4067-78.
PMID: 25187710
This study concentrates on the development of biodegradable nanofiber membranes with controlled drug release to ensure reduced tissue adhesion and accelerated healing. Nanofibers of poly(lactic-co-glycolic acid) (PLGA) loaded with epigallocatechin-3-O-gallate...